Revelation Biosciences: Gemini priming attenuates inflammatory response in PBMCs
Revelation Biosciences (REVB) announced Gemini priming attenuates the inflammatory response in human peripheral blood mononuclear cells exposed ...
Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells
Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is ...
Agri Investor5d
Big Idea Ventures closes VC food fund on $53m and plans quick follow-up
Chief investment officer and former Tyson Ventures executive Tom Mastrobuoni says corporates have backed away from fund ...
Hosted on MSN2mon
Targeting tristetraprolin in basophils: Researchers find promising therapeutic target for allergic inflammation
Basophils from each strain were stimulated with antigen combined with IgE, IL-33, or lipopolysaccharide (LPS). We measured gene expression, mRNA stability, and inflammatory protein levels.
Nature10y
Seeing mTOR in a new light
The drug blocks the activity of a protein known as mammalian target of ... infection or following exposure to lipopolysaccharide (LPS). Unexpectedly, rapamycin-mediated inhibition of mTOR caused ...